Clodagh Keohane

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Jyoti Nangalia, Charles Massie, E. Joanna Baxter et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Medicine, Genetics, Molecular Genetics +15

<scp>JAK</scp> inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells

Clodagh Keohane, Shahram Kordasti, Thomas Seidl et al. · British Journal of Haematology · 2015 · 105 citations

Life Sciences, Immunology, Oncology +17

Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib

Bridget S. Wilkins, D. Radia, C. Woodley et al. · Haematologica · 2013 · 78 citations · Full text

Medicine, Hematology, Pharmacology +15

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®)

Christopher L. Bacon, Evelyn Singleton, Bethany L. Brady et al. · Haemophilia · 2011 · 34 citations

Medicine, Hematology, Pharmacology +10

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis

Alexandros Rampotas, Matthew R. Wilson, Oliver Lomas et al. · British Journal of Haematology · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +15